Advanced Resin Therapeutics

Advanced Resin Therapeutics Overview

Founded 1999
Status Private
Latest Deal Type Later Stage VC (Upcoming)
Latest Deal Amount $2.5M
Latest Deal Amount
Investors 2

Advanced Resin Therapeutics General Information


Operator of a specialty pharmaceutical company intended to conduct research and development of a resin, trans-mucosal systemic delivery of active ingredients focused on the central nervous system. The company's formulations are designed to provide quick delivery of alprazolam for anxiety, ondansetron for nausea, sumitriptan for migraines, fentanyl for pain, Vardenafil and Sildenafil for erectile dysfunction and nicotine as an aid to smoking cessation, providing medical practitioners with a drug delivery system that promotes topical and transmucosal delivery of medications more efficiently and effectively than current technologies.

Contact Information

Formerly Known As
Jaleva Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Primary Office
  • 13073 Signature Point
  • Suite 202
  • San Diego, CA 92130
  • United States
+1 (858) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Advanced Resin Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC $2.5M Upcoming
3. Later Stage VC 03-Apr-2017 00.00 00.000 00.00 Completed Generating Revenue
2. Accelerator/Incubator 12-May-2016 $454K Completed Generating Revenue
1. Later Stage VC 27-May-2011 $454K $454K Completed Generating Revenue

Advanced Resin Therapeutics Cap Table

To view Advanced Resin Therapeutics‘s complete cap table, request access >>
Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series 1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000

Advanced Resin Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Howard Edelman Chief Executive Officer
Tracey Forester Chief Marketing Officer
Alex Battaglia Ph.D Co-Founder, Chief Scientific Officer & Board Member
Eva Beim Co-Founder, Executive Vice President of Strategic Relations and Global Business Development

1 Former Executive

Advanced Resin Therapeutics Board Members (2)

To view Advanced Resin Therapeutics‘s full board member team, request access >>
Name Representing Role Since
Alex Battaglia Ph.D Advanced Resin Therapeutics Co-Founder, Chief Scientific Officer & Board Member 000 0000

1 Former Board Member

Advanced Resin Therapeutics Investors (2)

To view Advanced Resin Therapeutics‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CONNECT (Accelerator) Accelerator/Incubator Minority 000 0000 000000 0
Button Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial